Immunotherapeutic potential of PD-1 blockade in chronic Leishmania mexicana infection through the enhancement of progenitor-like CXCR5+ and intermediate CXCR5+TIM-3+ exhausted T cells - Top-Institutions - MDSpire

Immunotherapeutic potential of PD-1 blockade in chronic Leishmania mexicana infection through the enhancement of progenitor-like CXCR5+ and intermediate CXCR5+TIM-3+ exhausted T cells

  • By

  • Mariana Diupotex

  • Julián A. Gajón

  • Laura C. Bonifaz

  • Jaime Zamora-Chimal

  • Ingeborg Becker

  • June 29, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    National Autonomous University of Mexico (UNAM) and IMSS Centro Médico Nacional Siglo XXI
    National Autonomous University of Mexico (UNAM) and IMSS Centro Médico Nacional Siglo XXI

    Mexico City, Mexico

    Key Differentiators

    • Infectious Disease
    • Immunology

  • #2

    National Institute of Allergy and Infectious Diseases (NIAID), NIH
    National Institute of Allergy and Infectious Diseases (NIAID), NIH

    Bethesda, Maryland

    Key Differentiators

    • Infectious Disease
    • Immunology

Original Source(s)

Immunotherapeutic potential of PD-1 blockade in chronic Leishmania mexicana infection through the enhancement of progenitor-like CXCR5+ and intermediate CXCR5+TIM-3+ exhausted T cells

  • by Mariana Diupotex, Julián A. Gajón, Laura C. Bonifaz, Jaime Zamora-Chimal, Ingeborg Becker

  • June 29, 2026

Related Content

Baihe Gujin decoction ameliorates sepsis-induced acute lung injury through Nrf2/GPX4-mediated antioxidant defense and PPARα-driven metabolic reprogramming: a multi-omics investigation

Can Tezepelumab Reduce Steroid Dependence?

Phase 3 SUNRISE trial evaluates whether patients with severe asthma can taper maintenance oral corticosteroids while maintaining asthma control.

Intranasal delivery of a polymeric nanoparticle subunit vaccine for the induction of protective immunity against respiratory syncytial virus